However, whether IL‐35 can directly upregulate the expression of LAIR1 to promote its inhibitory function in JSLE‐LN by suppressing the activation of JAK‐STAT3 signaling pathway, and the exact transcriptional factors involved in this regulation during the development of JSLE‐LN need further study. The gene discussed is LAIR1; the disease is lobular neoplasia.